Idylla ctEGFR Mutation Assay

49 EGFR mutations in exons 18, 19, 20 & 21

~160 minutes assay turnaround time

< 2 minutes hands-on time

Only 2 ml of plasma required

Suitable for any lab

Access on demand

The fully automated Idylla™ctEGFR Mutation Assay (RUO), fast and easy to perform, can be used to determine the EGFR mutation status using liquid biopsy plasma samples. Idylla™ctEGFR covers 49 EGFR mutations in exons 18, 19, 20 & 21 and showed high concordance compared to NGS.1

Download brochure

Download technical sheet

For research use only. Not for use in diagnostic procedures.

1Reijans et al.; ESMO poster 2019

Specimen requirements

One of the biggest challenges in oncology biomarker testing is the ability to obtain samples of sufficient size and quality. With the Idylla^TM System only a minimal amount of sample is needed

2 ml plasma collected using EDTA tubes

NOTE:

K₂EDTA tubes: process within 4 hours

The opinions and conclusions expressed in the following publications are those of the individual authors and do not necessarily reflect the views and opinions of Biocartis and/or its employees.

Feasibility study of a ctEGFR Prototype Assay on the fully automated Idylla platform

Reijans et al.; ESMO Poster 2019

Feasibility study comparing Idylla™ ctEGFR Mutation Assay* to NGS. The Idylla™ ctEGFR Mutation Assay* shows high concordance and ease of use combined with fast turnaround time for the testing of 49 relevant EGFR mutations in 2 ml of NSCLC plasma samples.

*Prototype

Discover all Research Assays

Back to overview